MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data.

Koch A, De Meyer T, Jeschke J, Van Criekinge W. · 2015

Read MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. by Koch A, De Meyer T, Jeschke J, Van Criekinge W. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4549898.txt.

Introduction

Alexander Koch, Tim De Meyer, Jana Jeschke, and Wim Van Criekinge built a web tool for cancer genome data, in BMC Genomics in 2015. The Cancer Genome Atlas has released vast gene and clinical data to the public. Yet if the data are hard to reach and read, most researchers cannot use them, and their value sits idle.

Their tool, MEXPRESS, draws gene activity, DNA methylation, and clinical details for one gene onto a single view. A demonstration on the gene GSTP1 in prostate cancer shows the layout at work. A second case revealed methylation differences in a breast cancer marker gene between subtypes, matched to expression changes. The tool is free online and aimed at clinical researchers with no coding background.

Catalog record

CREATORKoch A, De Meyer T, Jeschke J, Van Criekinge W.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4549898

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data By Alexander Koch, Tim De Meyer, Jana Jeschke, Wim Van Criekinge Published in: BMC Genomics DOI: 10.1186/s12864-015-1847-z ABSTRACT Background In recent years, increasing amounts of genomic and clinical cancer data have become publically available through large-scale collaborative projects such as The Cancer Genome Atlas (TCGA). However, as long as these datasets are difficult to access and interpret, they are essentially useless for a major part of the research community and their scientific potential will not be fully realized. To address these issues we developed MEXPRESS, a straightforward and easy-to-use web tool for the integration and visualization of the expression, DNA methylation and clinical TCGA data on a single-gene level (http://mexpress.be). Results In comparison to existing tools, MEXPRESS allows researchers to quickly visualize and interpret the different TCGA datasets and their relationships for a single gene, as demonstrated for GSTP1 in prostate adenocarcinoma. We also used MEXPRESS to reveal the differences in the DNA methylation status of the PAM50 marker gene MLPH between the breast cancer subtypes and how these differences were linked to the expression of MPLH. Conclusions We have created a user-friendly tool for the visualization and interpretation of TCGA data, offering clinical researchers a simple way to evaluate the TCGA data for their genes or candidate biomarkers of interest. Electronic supplementary material The online version of this article (doi:10.1186/s12864-015-1847-z) contains supplementary material, which is available to authorized users. BACKGROUND Over the last few years, large-scale cancer genomics projects have had a significant impact on cancer research. The goal of these projects is to create extensive, publically available and multidimensional oncogenomic datasets using high-throughput technologies. These datasets allow researchers to compare the genomic sequences, epigenetic profiles and transcriptomes of cancer cells to those of normal cells or cells of different cancer (sub)types. The Cancer Genome Atlas (TCGA), a joint effort of the National Cancer Institute and the National Human Genome Research Institute, is an example of such a project (http://cancergenome.nih.gov/). New findings derived from the statistical and data mining analysis of TCGA data are published regularly and have already proven to be a valuable addition to cancer research [1–4]. Large-scale datasets like TCGA also provide a validation platform for newly identified biomarkers and they are becoming a standard tool for current biomarker research. Another powerful aspect of the TCGA data is the possibility to correlate different types of data. Promoter DNA methylation for example influences gene expression, and aberrant methylation is found in almost every human cancer [5]. The ability to compare these data in a large number of cancer patients is therefore extremely valuable, especially for the identification of DNA methylation biomarkers. Given the growing importance of large-scale datasets for cancer research, intuitive data visualization tools are increasingly crucial to help researchers understand the data, especially when multiple samples and datasets have to be compared. A number of visualization tools, each focused on one or more specific research questions, are available for TCGA data and offer a wide range of visualization methods [6–9]. There is however no tool available that offers fast and straightforward visualization and interpretation of the expression, methylation and clinical data in TCGA, as well as the relation between these different data types. Such a tool could be of particular use to the large community of clinical researchers without bioinformatics expertise who are looking for a way to explore genes of interest or candidate biomarkers in the TCGA data. Here we introduce MEXPRESS, an intuitive web tool for the fast and straightforward querying and visualization of the clinical, expression and methylation data in TCGA and the relationship between these datasets on a single-gene level. MEXPRESS was designed after the principles of graphical excellence as described by Edward Tufte [10] to ensure that the complex and multidimensional TCGA data would be presented in a clear, precise and efficient way to the user. It is generally accepted that analysis and visualization tools intended for a broad research audience should be easy to use and should not require computational or bioinformatics expertise [7, 9, 11, 12]. MEXPRESS was therefore developed to have virtually no learning curve, allowing especially clinical researchers to get their results fast without having to invest time in learning yet another tool. IMPLEMENTATION Ease of use is a key feature of MEXPRESS. Just three simple steps are needed to create a plot: a user has to enter a gene name, select one of the available cancer types and click the plot button. The resulting figure (Figs. 1 and 2) shows the selected gene together with its transcripts and any CpG islands. Next to the gene, blue line plots illustrate the methylation data for each probe location (Infinium HumanMethylation450 microarray data). A yellow line plot displays the RNA-seq-derived expression data and grey bar plots represent the values of the clinical parameters. The numbers on the far right indicate the significance of the relation (correlation coefficient or P value, depending on the data types compared) between each row of data (clinical, expression or methylation) and the selected “sorter”. By default, expression is the selected “sorter”, which means that the samples are ordered by their expression value. Clicking on one of the clinical parameters will reorder the samples based on the selected variable and the relationships will be recalculated. The resulting images can be downloaded in PNG or SVG file format.Fig. 1Visualization of the TCGA data for GSTP1 in prostate adenocarcinoma using MEXPRESS. a In the default MEXPRESS plot, the samples are ordered by their expression value. This view shows how GSTP1 expression and promoter methylation are negatively correlated, which is confirmed by the Pearson correlation coefficients on the right. It also indicates that normal samples tend to have higher GSTP1 expression than tumor samples. b When reordered by sample type, the differences in expression and methylation between normal and tumor samples become even more apparentFig. 2MEXPRESS view of the TCGA data for MLPH in breast invasive carcinoma. The samples are ordered by breast cancer subtype, revealing clear differences in expression and methylation, as well as HER2, estrogen and progesterone receptor status, between the different subtypes TCGA data We downloaded the following TCGA data from the TCGA ftp site: level 3 per-gene RNA-seq v2 expression data (UNC IlluminaHiSeq_RNASeqV2), level 3 DNA methylation data (JHU_USC HumanMethylation450) and clinical data in Biotab format (both clinical patient and tumor sample data). Bash scripts running on the back-end Linux server check the TCGA ftp site monthly for any data updates, which are then automatically uploaded to the database. Whenever TCGA publishes data for new cancer types, these will also be included in MEXPRESS. Before the upload, R scripts (R version 3.0.2) process the data to address missing values, to combine separate files into one where necessary, to reformat the data and to generate SQL scripts for the data upload. The RNA-seq data is log-transformed before being used to draw the plots and only a selection of the most relevant clinical parameters (for which data is available) is shown in the MEXPRESS plots in order to reduce data clutter. Other data sources For the breast invasive carcinoma samples, we downloaded a table with the expression subtype (normal, basal, luminal A, luminal B and Her2)

Read the complete text